JB Chemicals & Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Court Convened General Meeting held on April 28, 2026. Further, the company has informed the Exchange regarding voting results.
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
JB Chemicals & Pharmaceuticals shareholders approved, with overwhelming support, the proposed Scheme of Amalgamation with Torrent Pharmaceuticals Limited at the NCLT-convened meeting held on April 28, 2026. Promoters voted 100% in favor (7.83 crore shares), while public shareholders approved the scheme 99.02% in favor and only 0.98% against (just 2,185 shares voted against out of 5.20 crore polled). The resolution was passed by the required three-fourths majority in value under Section 230(6) of the Companies Act and also cleared the SEBI public shareholder threshold test. A total of 13.04 crore equity shares were polled, with 99.998% in favor of the merger. The scheme now moves to the next stage of NCLT approval for the amalgamation to take effect.
This is a key milestone in the JB Pharma–Torrent Pharma merger — shareholder approval clears the way for NCLT sanction. Once effective, JB Pharma shareholders will likely receive shares of Torrent Pharma as per the swap ratio, making this a significant event for the stock and shareholder composition.